Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2013-04-30
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015
Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
NCT02147509
Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed With Dry Eye Disease in A Sample of Egyptian Patients
NCT05598437
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry Eye
The patients with Sjogren Syndrome related or non-Sjogren Syndrome related dry eye. The participants will be asked some questions. Before and after reading a text silently in 30 minutes "30 minutes sustained reading", a detailed dry eye exam will be performed.
30 minutes sustained reading
The participants will be given a text to read silently in 30 minutes.
Dry eye exam
Tear break-up time, tear collection, osmolarity, Schirmer test, corneal and conjunctival staining.
Controls
The patients without dry eye. The participants will be asked some questions. Before and after reading a text silently in 30 minutes "30 minutes sustained reading", a detailed dry eye exam will be performed.
30 minutes sustained reading
The participants will be given a text to read silently in 30 minutes.
Dry eye exam
Tear break-up time, tear collection, osmolarity, Schirmer test, corneal and conjunctival staining.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
30 minutes sustained reading
The participants will be given a text to read silently in 30 minutes.
Dry eye exam
Tear break-up time, tear collection, osmolarity, Schirmer test, corneal and conjunctival staining.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* literacy in English language,
* ability to give informed consent
Exclusion Criteria
* any ocular surgery within the last 3 months,
* mental issues,
* illiteracy,
* language problems which might possibly interfere with reading ability,
* history of taking or current use of topical prescription anti-inflammatory eye drops (including, cyclosporine and steroids as well as any glaucoma eye drops).
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esen K Akpek, MD
Role: PRINCIPAL_INVESTIGATOR
The Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Wilmer Eye Institute, Johns Hopkins University
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA_00082755
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.